Effect of recombinant osteopontin on cerebral vasospasm after subarachnoid hemorrhage in rats

Acta Neurochirurgica, Supplementum

Volumn 110, Issue , 2011, Pages 29-32

  Suzuki, Hidenori ^a   Hasegawa, Yu ^a   Kanamaru, Kenji ^b   Zhang, John H ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Suzuka Kaisei Hospital   (Japan)

Author keywords

Casting method; Cerebral vasospasm; Osteopontin; Subarachnoid hemorrhage

Indexed keywords

RECOMBINANT CYTOKINE; RECOMBINANT OSTEOPONTIN; UNCLASSIFIED DRUG;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN VASOSPASM; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; NONHUMAN; PERFORATION; RAT; SHAM PROCEDURE; SUBARACHNOID HEMORRHAGE;

EID: 85052609855     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0356-2_6     Document Type: Conference Paper

References (10)

1. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 2001;60:1645-1657
2. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. Osteopontin. A molecule for all seasons. Q J Med. 2002; 95:3-13
3. Suzuki H, Ayer R, Sugawara T, Chen W, Sozen T, Hasegawa Y, et al. Protective effects of recombinant osteopontin on early brain injury after subarachnoid hemorrhage in rats. Crit Care Med. 2010;38:612-618
4. Sugawara T, Ayer R, Jadhav V, Zhang JH. A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Meth. 2008;167:327-334
5. Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: Methodological analysis. Neurol Res. 2002; 24:510-516
6. Zheng J-S, Zhan R-Y, Zheng S-S, Zhou Y-Q, Tong Y, Wan S. Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats. Stroke 2005;36:1059-1064
7. Arafat HA, Katakam AK, Chipitsyna G, Gong Q, Vancha AR, Gabbeta J, et al. Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide. Endocrinology 2007;148:575-584
8. Guo H, Wai PY, Mi Z, Gao C, Zhang J, Kuo PC. Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis. Surgery 2008;144:182-188
9. Pannu R, Singh I. Pharmacological strategies for the regulation of inducible nitric oxide synthase. Neurodegenerative versus neuroprotective mechanisms. Neurochem Int. 2006;49:170-182
10. Xie Z, Singh M, Siwik DA, Joyner WL, Singh K. Osteopontin inhibits interleukin-1beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: Role of protein kinase C-zeta. J Biol Chem. 2003;278:48546-48552